(Q37785326)

23 August 2017

title

Humoral autoimmunity in multiple sclerosis (English)

1 reference

23 August 2017

0 references

1

Edgar Meinl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20817206

6 July 2024

author name string

Tobias Derfuss

2

1 reference

23 August 2017

Markus Krumbholz

3

1 reference

23 August 2017

Anne-Katrin Pröbstel

4

1 reference

23 August 2017

Reinhard Hohlfeld

5

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20817206

6 July 2024

publication date

3 September 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0022510X10003588?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

https://api.elsevier.com/content/article/PII:S0022510X10003588?httpAccept=text/plain

6 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Journal of the Neurological Sciences

6 July 2024

published in

1 reference

23 August 2017

volume

306

1 reference

23 August 2017

issue

1-2

1 reference

23 August 2017

page(s)

180-182

1 reference

B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

6 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.

6 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

6 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

6 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

6 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

6 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Antigen-specific interaction between T and B cells

6 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients

6 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

6 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Expression and function of glial cell line-derived neurotrophic factor family ligands and their receptors on human immune cells

6 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Invited article: human natural autoantibodies in the treatment of neurologic disease

6 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

The role of APRIL and BAFF in lymphocyte activation

6 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

6 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.

6 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions

6 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions

6 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation

6 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity

6 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.

6 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination

6 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Atacicept: targeting B cells in multiple sclerosis

6 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Identification of BLyS (B lymphocyte stimulator), a non-myelin-associated protein, as a functional ligand for Nogo-66 receptor.

6 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

6 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Neuromyelitis optica: Passive transfer to rats by human immunoglobulin

6 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica

6 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

6 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis

6 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease

6 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Novel approaches for identifying target antigens of autoreactive human B and T cells

6 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Neurofascin as a novel target for autoantibody-mediated axonal injury

6 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals

6 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury.

6 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

6 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2010.08.009

6 July 2024

Identifiers

1 reference

23 August 2017

1 reference